1
|
Srivastava S, Ratho RK, Singh MP, Sarkar S, Pati BK. Molecular characterization and evolutionary dynamics of influenza A(H1N1) strains isolated from 2015 to 2017 in North India. IRANIAN JOURNAL OF MICROBIOLOGY 2024; 16:243-250. [PMID: 38854978 PMCID: PMC11162167 DOI: 10.18502/ijm.v16i2.15358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/11/2024]
Abstract
Background and Objectives The influenza A(H1N1) virus is known for large outbreaks, epidemics and pandemics worldwide owing to its genome plasticity which evolves constantly. In the year 2015 and then in 2017, India witnessed an upsurge in cases. Materials and Methods The study was carried out in this period (2015-2017) with samples from 5 states across north India. The hemagglutinin 1 (HA1) and non-structural 1 (NS1) gene segments of the viral genome were characterised by phylogenetic analysis, selection pressure analysis, prediction of potential glycosylation sites and phylodynamic analysis of the study strains. Results The study strains belonged to genogroup 6B. A total of 12 mutations were observed, half of which were located on the key receptor binding region of the HA1 protein. Established virulence markers D222G, S183P were observed in 2017 samples. Acquisition of an extra glycosylation site was observed in few strains from 2017 and 2016. Selection pressure analysis found the average dN/dS (v) ratio of 0.2106 and few codon sites in particular showed significant evidence of being under negative selection. Conclusion The genogroup 6B continues to be the dominant circulating strain in Indian subcontinent region however the presence of pathogenic mutations in the 2017 strains from north India underlines the importance of continued molecular surveillance.
Collapse
Affiliation(s)
- Sonakshi Srivastava
- Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
- Department of Microbiology, Hind Institute of Medical Sciences, Barabanki, India
| | - Radha Kanta Ratho
- Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
| | - Mini P Singh
- Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
| | - Subhabrata Sarkar
- Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
| | - Binod K Pati
- Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
| |
Collapse
|
2
|
Kyaw Win SM, Saito R, Win NC, Lasham DJ, Kyaw Y, Lin N, Thein KN, Chon I, Odagiri T, Thein W, Kyaw LL, Tin OS, Saitoh A, Tamura T, Hirokawa C, Uchida Y, Saito T, Watanabe S, Odagiri T, Kamata K, Osada H, Dapat C, Watanabe H, Tin HH. Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017. PLoS One 2020; 15:e0229601. [PMID: 32130243 PMCID: PMC7055873 DOI: 10.1371/journal.pone.0229601] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2019] [Accepted: 02/10/2020] [Indexed: 12/16/2022] Open
Abstract
A community outbreak of human influenza A(H1N1)pdm09 virus strains was observed in Myanmar in 2017. We investigated the circulation patterns, antigenicity, and drug resistance of 2017 influenza A(H1N1)pdm09 viruses from Myanmar and characterized the full genome of influenza virus strains in Myanmar from in-patients and out-patients to assess the pathogenicity of the viruses. Nasopharyngeal swabs were collected from out-patients and in-patients with acute respiratory tract infections in Yangon and Pyinmana City in Myanmar during January-December 2017. A total of 215 out-patients and 18 in-patients infected with A(H1N1)pdm09 were detected by virus isolation and real-time RT-PCR. Among the positive patients, 90.6% were less than 14 years old. Hemagglutination inhibition (HI) antibody titers against A(H1N1)pdm09 viruses in Myanmar were similar to the recommended Japanese influenza vaccine strain for 2017-2018 seasons (A/Singapore/GP1908/2015) and WHO recommended 2017 southern hemisphere vaccine component (A/Michigan/45/2015). Phylogenetic analysis of the hemagglutinin sequence showed that the Myanmar strains belonged to the genetic subclade 6B.1, possessing mutations of S162N and S164T at potential antigenic sites. However, the amino acid mutation at position 222, which may enhance the severity of disease and mortality, was not found. One case with no prior history of oseltamivir treatment possessed H275Y mutated virus in neuraminidase (NA), which confers resistance to oseltamivir and peramivir with elevated IC50 values. The full genome sequence of Myanmar strains showed no difference between samples from in-patients and out-patients, suggesting no additional viral mutations associated with patient severity. Several amino acid changes were observed in PB2, PB1, and M2 of Myanmar strains when compared to the vaccine strain and other Asian strains. However, no mutations associated with pathogenicity were found in the Myanmar strains, suggesting that viral factors cannot explain the underlying reasons of the massive outbreak in Myanmar. This study reported the first detection of an oseltamivir-resistant influenza virus in Myanmar, highlighting the importance of continuous antiviral monitoring and genetic characterization of the influenza virus in Myanmar.
Collapse
MESH Headings
- Adolescent
- Adult
- Amino Acid Substitution
- Antigens, Viral
- Antiviral Agents/pharmacology
- Child
- Child, Preschool
- Drug Resistance, Viral/genetics
- Epidemics
- Female
- Genome, Viral
- Hemagglutinin Glycoproteins, Influenza Virus/genetics
- Hemagglutinin Glycoproteins, Influenza Virus/immunology
- Humans
- Infant
- Influenza A Virus, H1N1 Subtype/classification
- Influenza A Virus, H1N1 Subtype/genetics
- Influenza A Virus, H1N1 Subtype/immunology
- Influenza, Human/drug therapy
- Influenza, Human/epidemiology
- Influenza, Human/virology
- Male
- Middle Aged
- Mutation, Missense
- Myanmar/epidemiology
- Oseltamivir/pharmacology
- Phylogeny
- Young Adult
Collapse
Affiliation(s)
- Su Mon Kyaw Win
- Infectious Diseases Research Center of Niigata University in Myanmar (IDRC), Yangon, Yangon Region, Myanmar
| | - Reiko Saito
- Infectious Diseases Research Center of Niigata University in Myanmar (IDRC), Yangon, Yangon Region, Myanmar
- Division of International Health, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Niigata, Japan
| | - Nay Chi Win
- Infectious Diseases Research Center of Niigata University in Myanmar (IDRC), Yangon, Yangon Region, Myanmar
| | - Di Ja Lasham
- Infectious Diseases Research Center of Niigata University in Myanmar (IDRC), Yangon, Yangon Region, Myanmar
| | - Yadanar Kyaw
- Respiratory Medicine Department, Thingangyun Sanpya General Hospital, Yangon, Yangon Region, Myanmar
| | - Nay Lin
- Clinical Laboratory, Microbiology Section, Pyinmana General Hospital, Pyinmana Township, Nay Pyi Taw, Myanmar
| | - Khin Nyo Thein
- Pediatric Ward 1, Yankin Children Hospital, Yangon, Yangon Region, Myanmar
| | - Irina Chon
- Division of International Health, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Niigata, Japan
| | - Takashi Odagiri
- Department of Microbiology, Infectious diseases and Immunology, Iwate Medical University, Morioka, Iwate, Japan
| | - Win Thein
- National Health Laboratory, Department of Medical Services, Ministry of Health and Sports, Yangon, Yangon Region, Myanmar
| | - Latt Latt Kyaw
- National Health Laboratory, Department of Medical Services, Ministry of Health and Sports, Yangon, Yangon Region, Myanmar
| | - Ommar Swe Tin
- National Health Laboratory, Department of Medical Services, Ministry of Health and Sports, Yangon, Yangon Region, Myanmar
| | - Akihiko Saitoh
- Department of Pediatrics, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Niigata, Japan
| | - Tsutomu Tamura
- Division of Virology, Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata, Niigata, Japan
| | - Chika Hirokawa
- Division of Virology, Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata, Niigata, Japan
| | - Yuko Uchida
- Division of Transboundary Animal Disease, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki, Japan
| | - Takehiko Saito
- Division of Transboundary Animal Disease, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki, Japan
| | - Shinji Watanabe
- Laboratory of Influenza Virus Surveillance, Influenza Research Center, National Institute of Infectious Diseases, Sinjuku-ku, Tokyo, Japan
| | - Takato Odagiri
- Laboratory of Influenza Virus Surveillance, Influenza Research Center, National Institute of Infectious Diseases, Sinjuku-ku, Tokyo, Japan
| | - Kazuhiro Kamata
- Infectious Diseases Research Center of Niigata University in Myanmar (IDRC), Yangon, Yangon Region, Myanmar
- Institute of Medicine and Dentistry, Niigata University, Niigata, Japan
| | - Hidekazu Osada
- Infectious Diseases Research Center of Niigata University in Myanmar (IDRC), Yangon, Yangon Region, Myanmar
- Institute of Medicine and Dentistry, Niigata University, Niigata, Japan
| | - Clyde Dapat
- Department of Virology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Hisami Watanabe
- Infectious Diseases Research Center of Niigata University in Myanmar (IDRC), Yangon, Yangon Region, Myanmar
- Institute of Medicine and Dentistry, Niigata University, Niigata, Japan
| | - Htay Htay Tin
- National Health Laboratory, Department of Medical Services, Ministry of Health and Sports, Yangon, Yangon Region, Myanmar
| |
Collapse
|
3
|
Saha P, Biswas M, Gupta R, Majumdar A, Mitra S, Banerjee A, Mukherjee A, Dutta S, Chawla-Sarkar M. Molecular characterization of Influenza A pandemic H1N1 viruses circulating in eastern India during 2017-19: Antigenic diversity in comparison to the vaccine strains. INFECTION GENETICS AND EVOLUTION 2020; 81:104270. [PMID: 32142936 DOI: 10.1016/j.meegid.2020.104270] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2019] [Revised: 02/08/2020] [Accepted: 03/02/2020] [Indexed: 11/27/2022]
Abstract
In the endemic settings of India, high CFR (3.6-7.02%) was observed in the consecutive 2009, 2015 and 2017 A/H1N1pdm09 outbreaks, though in eastern India CFR varied between 0 and 5.5% during same period. Recurrent outbreaks of pandemic Influenza A/H1N1pdm09, fragmented nationwide incidence data, lack of national policy for Influenza vaccination in India underscores the necessity for generating regional level data. Thus, during 2017-19, 4106 referred samples from patients hospitalized with severe acute respiratory illness (SARI) in eastern India were tested for A/H1N1pdm09 infection. Among which 16.5% (n = 677/4106) were found A/H1N1pdm09 positive. Individuals <20 years and middle-aged persons (40-60 years) were most susceptible to A/H1N1pdm09 infection. The vaccine strain (A/human/California/07/2009) which was globally used before 2017, clustered in a different lineage away from the representative eastern Indian strains in the phylogenetic dendrogram. The vaccine strain (A/human/Michigan/45/2015) used in India during the study period and the WHO recommended strain (A/human/Brisbane/02/2018) for 2019-20 flu season for the northern hemisphere, clustered with the circulating isolates in the same lineage-6b. Dissimilarities in the amino acids encompassing the antigenic epitopes were seen to be highest with the vaccine strain- A/human/California/07/2009. The significant amino acid variations in the circulating strains with the current WHO recommended vaccine strain, implies the exigency of continuous pandemic A/H1N1pdm09 surveillance studies in this epidemiological setting. The absence of any Oseltamivir resistant mutation (H275Y) in the neuraminidase gene of the current isolates suggests continuing use of Tamiflu® as an antiviral therapy in suspected subjects in this region.
Collapse
Affiliation(s)
- Priyanka Saha
- Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
| | - Madhumonti Biswas
- Regional Virus Research and Diagnostic Lab, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
| | - Rudrak Gupta
- Regional Virus Research and Diagnostic Lab, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
| | - Agniva Majumdar
- Regional Virus Research and Diagnostic Lab, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
| | - Suvrotoa Mitra
- Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
| | - Anindita Banerjee
- Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
| | | | - Shanta Dutta
- Regional Virus Research and Diagnostic Lab, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
| | - Mamta Chawla-Sarkar
- Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.
| |
Collapse
|
4
|
Potdar V, Vijay N, Gupta N, Arunkumar G, Borkakoty B, Malhotra B, Rabha D, Hinge D, Kaur H, Chadha M. Molecular characterization of influenza A(H1N1)pdm09 viruses circulating at various geographical locations in India, 2017. Indian J Med Res 2020; 149:783-789. [PMID: 31496532 PMCID: PMC6755778 DOI: 10.4103/ijmr.ijmr_925_18] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Background & objectives Influenza virological surveillance is an essential tool for the early detection of novel genetic variants of epidemiologic and clinical significance. This study was aimed to genetically characterize A(H1N1)pdm09 virus circulating in 2017 and to compare it with the global data. Methods The regional/State Viral Research and Diagnostic Laboratories (VRDLs) provided influenza diagnosis for referred clinical samples and shared influenza A(H1N1)pdm09 positives with the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, India, for hemagglutinin (HA) gene phylogenetic analysis. Sites at Manipal, Jaipur and Dibrugarh performed the sequencing and shared the sequence data for analysis. The antiviral susceptibility of influenza viruses was assessed for known molecular marker H275Y at the ICMR-NIV, Pune. Results All the eight VRDLs had well-established influenza diagnostic facilities and showed increased activity of influenza A(H1N1)pdm09 during 2017. Phylogenetic analysis showed that the viruses from the different regions of the country were similar to A/Michigan/45/2015 strain which was the 2017-2018 recommended vaccine strain and were clustered with the globally circulating clade 6B.1 with signature mutations S84N, S162N and I216T. The clade 6B.1 showed further subgrouping with additional mutations S74R, S164T and I295V; however, there was no significant association between the presence of these mutations and severity of disease due to influenza. All the study viruses were sensitive to oseltamivir. Interpretation & conclusions During the study period, all the study sites reported globally circulating A/Michigan/45/2015 vaccine strain of influenza A(H1N1)pdm09 viruses and remained sensitive to oseltamivir. Further genetic and antigenic characterization of influenza viruses is recommended to address public health concerns.
Collapse
Affiliation(s)
- Varsha Potdar
- Influenza Group, ICMR-National Institute of Virology, Pune, India
| | - Neetu Vijay
- Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India
| | - Nivedita Gupta
- Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, Headquarters, New Delhi, India
| | - G Arunkumar
- Manipal Institute of Virology, Manipal Academy of Higher Education (Deemed to be University), Manipal, India
| | | | - Bharti Malhotra
- Department of Microbiology, Sawai Man Singh Medical College, Jaipur, India
| | - Debajit Rabha
- Department of Microbiology, Guwahati Medical College, Guwahati, India
| | - Dilip Hinge
- Influenza Group, ICMR-National Institute of Virology, Pune, India
| | - Harmanmeet Kaur
- Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India
| | - Mandeep Chadha
- Influenza Group, ICMR-National Institute of Virology, Pune, India
| | | |
Collapse
|
6
|
Pandey S, Sahu M, Potdar V, Barde P. Molecular analysis of influenza A H1N1pdm09 virus circulating in Madhya Pradesh, India in the year 2017. Virusdisease 2018; 29:380-384. [PMID: 30159375 PMCID: PMC6111952 DOI: 10.1007/s13337-018-0474-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2018] [Accepted: 07/07/2018] [Indexed: 10/28/2022] Open
Abstract
Influenza A (H1N1) pdm09 emerged as a major public health problem in 2009. The virus has evolved since then and has acquired several mutations that are epidemiologically important. Viral hemagglutinin (HA) protein is crucial determinant for virus entry, antigenicity, and virulence. The information regarding amino acid substitutions in HA protein of viruses circulating in India during 2017 is lacking. We sequenced HA gene of Influenza A (H1N1) pdm09 detected in Central India and compared the amino acid sequences with present vaccine component and contemporary Influenza A (H1N1) pdm09 sequences. We observed 7 amino acid changes of which two (T508A and I510T) were novel to Central Indian strain. Further, the substitution of Aspartate by Glycine at 222, which is known to have clinical implications, was detected in sequences from western India. The phylogenetic analysis revealed that the circulating virus belonged to clade 6B.1. The appreciable acquired mutations by the virus are not important antigenically and the present vaccine provides effective protection. On the other hand, the amino acid substitutions may play important role in epidemiology; we suggest rigorous molecular monitoring and documentation for timely interventions.
Collapse
Affiliation(s)
- Salonee Pandey
- Division of Virology and Zoonoses, ICMR-National Institute for Research in Tribal Health, Nagpur Road, Jabalpur, MP India
| | - Mahima Sahu
- Division of Virology and Zoonoses, ICMR-National Institute for Research in Tribal Health, Nagpur Road, Jabalpur, MP India
| | - Varsha Potdar
- Influenza Division, ICMR-National Institute of Virology, 20-A Dr. Ambedkar Road Camp, Pune, 411001 India
| | - Pradip Barde
- Division of Virology and Zoonoses, ICMR-National Institute for Research in Tribal Health, Nagpur Road, Jabalpur, MP India
| |
Collapse
|